Gartner Research

Hype Cycle for Life Science Research and Development, 2017

Published: 17 July 2017

ID: G00314538

Analyst(s): Michael Shanler , Jeff Smith

Summary

CIOs are moving from strategy into the execution phase for digital R&D and are implementing a range of technologies to develop new drugs, devices and therapies. Success requires leaders to choreograph a diverse set of scientific, laboratory and clinical technologies in a fluid business environment.

Table Of Contents

Analysis

  • What You Need to Know
  • The Hype Cycle
  • The Priority Matrix
  • Off the Hype Cycle
  • On the Rise
    • IoT-Enabled Laboratory
    • Physician-Prescribed Clinical Apps
    • eSource
    • Blockchain in Life Science
    • RWE for Clinical Trials
    • Nanomedicine
    • Centralized Monitoring/RBM
  • At the Peak
    • Augmented Data Discovery
    • Wearable Devices for Clinical Trials
    • Lab Apps
    • Clinical Trial Data Transparency
    • Insight Engines
    • SaaS-Regulated EDMS
    • Machine Learning
    • Adaptive Trials
    • Enterprise Laboratory Informatics
    • Genomics Medicine
    • 3D Bioprinting for Life Science R&D
    • Cloud-Based Drug Discovery Platform
    • Data Lakes
    • SaaS-LIMS
  • Sliding Into the Trough
    • 3D Printing of Medical Devices
    • Patient Communities for Trial Recruitment
    • SaaS ELN
    • Semantic Knowledge Graphing
    • Compliant GxP Cloud
    • Precompetitive Alliances
    • Big Data in R&D
    • EHR-Based Clinical Studies
    • Innovation Management Technology for Product Development
    • Enterprise IP Management
    • Pharma PLM
    • Scientific Text Analytics and Annotators
  • Climbing the Slope
    • Clinical Resource Management
    • E-Clinical Application Suites
    • eTMF
    • Structure Content and Component Authoring
    • ELN
    • Global Regulatory Information Management
    • Scientific Analytics Platforms
    • Medical Devices — PLM
  • Entering the Plateau
    • Advanced Clinical Research Information Systems
    • Signal Detection
    • ePRO, E-Patient Diaries and eCOA
    • LIMS
  • Appendixes
    • Hype Cycle Phases, Benefit Ratings and Maturity Levels

Gartner Recommended Reading

©2019 Gartner, Inc. and/or its affiliates. All rights reserved. Gartner is a registered trademark of Gartner, Inc. and its affiliates. This publication may not be reproduced or distributed in any form without Gartner’s prior written permission. It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact. While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information. Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such. Your access and use of this publication are governed by Gartner’s Usage Policy. Gartner prides itself on its reputation for independence and objectivity. Its research is produced independently by its research organization without input or influence from any third party. For further information, see Guiding Principles on Independence and Objectivity.

Already have a Gartner Account?

Become a client